FutureTox V: New Technologies to Evaluate Organ-Specific Effects of Drugs and Chemicals

The Society of Toxicology will host FutureTox V: New Technologies to Evaluate Organ-Specific Effects of Drugs and Chemicals on 10-11 May 2022 in Chapel Hill, North Carolina.

The FutureTox series focuses on building the road for 21st-century toxicology and risk assessment practices, utilizing in vitro data and in silico models for predictive toxicology, and taking the high-throughput risk assessment paradigm forward to address challenges in implementing the emerging big-data toolbox for risk assessment and regulatory decision-making.

Highlighted topics of interest include:

• Modeling environment for organ-specific computational synthesis and integration
• Novel single cell sequencing-based technologies
• In silico models of organ-specific effects
• FDA, EPA discussion on future tech and research needs to evaluate organ-specific effects of drugs and chemicals
• FDA, EPA discussion on opportunities for regulators to use new models and technologies in evaluating organ-specific effects of drugs and chemicals
• NIEHS/NICEATM, EPA breakout discussion of ‘big data’ stream utilization in toxicology and risk assessment
• Advantages and barriers to application of new models for evaluating effects of drugs and chemicals on the blood-brain barrier
• Perfused microphysiological systems
• Liver spheroids and micropatterned cultures
• Modeling the gut microbiome
• Air-liquid interface models for airway safety assessment
• Opportunities to advance IVIVE with physiological organ-specific models

Please visit the Society of Toxicology’s FutureTox V website for more information.